DBV Technologies - Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
| Date | Total number of shares | Total number of voting rights |
| 03/31/2024 | 96,434,369 | Total gross of voting rights: 96,434,369 |
| Total net* of voting rights: 96,171,725 |
* Net total = total number of voting rights attached to shares – shares without voting rights
| Last Trade: | US$16.43 |
| Daily Change: | 1.43 9.53 |
| Daily Volume: | 238,949 |
| Market Cap: | US$449.390M |
October 06, 2025 July 22, 2025 | |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
